FindTrial
Sign In

To compare thromboelastography with coagulation tests to assess the coagulation status of patients with primary brain tumour undergoing surgery

Comparison Of Thromboelastography With Conventional Coagulation Tests To Evaluate The Haemostatic Profile Of Patients With Primary Brain Tumour Undergoing Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/03/018219
Enrollment
40
Registered
2019-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C69-C72- Malignant neoplasms of eye, brain and other parts of central nervous system

Interventions

None listed

Sponsors

Dr Monica Kohli
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all newly diagnosed patients with primary brain tumors larger than 4cm in maximum diameter on CT

Exclusion criteria

Exclusion criteria: patients with history of haematological or coagulation disorders, those taking anticoagulant therapy and those with chronic disease for example , liver cirrhosis or renal failure.

Design outcomes

Primary

MeasureTime frame
To investigate the clinical variables and changes in haemostaic profile occurring during surgery for primary brain tumors using a combination of TEG and traditional tests Timepoint: August,2019—

Secondary

MeasureTime frame
to evaluate the hypercoagulable hemostatic status periopratively by TEG to assess the the blood component support during brain tumors surgeryTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Vikalp Khatri

King George Medical University

monica_kohli@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026